Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Triple Antiviral Does Well in Study

August 30, 2010 7:35 am | News | Comments

Adamas Pharmaceuticals, Inc. announced the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients.


FDA Approves Tekamlo

August 30, 2010 7:19 am | News | Comments

The US Food and Drug Administration approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna, with the widely used calcium channel blocker amlodipine.


Cryogenic Vials

August 27, 2010 8:47 am | Product Releases | Comments

Wheaton Science Products has announced that its CryoELITE Cryogenic Vials are CE marked in accordance with the requirements of Directive 8/79/EC on in vitro diagnostic medical devices.


HPLC Injector

August 27, 2010 8:40 am | News | Comments

VICI Valco’s Cheminert C52 Series Injector presents its first integrated motor/valve assembly designed specifically to be built into an OEM system.


Chindex Sells $14M Worth of Shares

August 27, 2010 8:24 am | News | Comments

Chindex International sold $14 million of its shares to another Chinese medical concern as part of its plans to form a new joint venture, the company said.


Ambry Adds HiSeq and BeadXpress Instruments

August 27, 2010 8:19 am | News | Comments

Ambry Genetics, a global leader in genomic services, announced that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System as well as received the first 510(K) approved Illumina BeadXpress Genotyping System.


Artificial Enzyme Removes Natural Poison

August 27, 2010 8:16 am | News | Comments

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables.


Possible New Antibiotic Discovered

August 27, 2010 8:12 am | News | Comments

Scientists at the University of East Anglia, have shown that fungus-farming ants are using multiple antibiotics as weed killers to maintain their fungus gardens.


FDA Refuses to Speed Approval of Genentech Cancer Drug

August 27, 2010 8:07 am | News | Comments

Genentech announced the U.S. Food and Drug Administration issued a Refuse to File letter for accelerated approval for the company's trastuzumab-DM1 (T-DM1) Biologics License Application (BLA).


European Commision Grants Authorization for Gaucher Treatment

August 27, 2010 8:03 am | News | Comments

Shire plc announced that the European Commission has granted marketing authorisation for VPRIV (velaglucerase alfa), a human cell line derived enzyme replacement therapy for the long-term treatment of type 1 Gaucher disease.


Montana Governor Aims to Lower Drug Prices

August 27, 2010 7:57 am | by Matt Gouras | News | Comments

Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid.


EMA Investigating Vaccine-Narcolepsy Link

August 27, 2010 7:54 am | News | Comments

The European Medicines Agency has issued a statement saying that there have been a "limited" number of narcolepsy cases in people mainly in Sweden and Finland who got the Pandemrix shot, made by GlaxoSmithKline PLC.


A Novel Approach to Treating Peripheral Arterial Disease

August 26, 2010 10:20 am | by Helen Marie Nugent, PhD, Co-Founder and Vice President, Research and Development; Pervasis Therapeutics, Cambridge, Mass. | Articles | Comments

In the United States, over eight million adults over age 50 suffer from peripheral arterial disease (PAD), a serious condition that commonly results from progressive narrowing of arteries in the lower extremities due to atherosclerosis.


Purification System

August 26, 2010 9:49 am | Product Releases | Comments

Gilson, Inc. introduces a personal bench top purification system. The Gilson PLC 2020 Personal Purification System provides a complete, compact design with interchangeable pump heads.


Cell Transfection System

August 26, 2010 9:42 am | Product Releases | Comments

Lonza’s 4D-Nucleofector System is lifting the Amaxa Nucleofector Technology to the next dimension. Lonza engineers and scientists have developed a system which is designed for maximum flexibility combined with advanced performance and convenience.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.